---
title: "Pharscin Pharma Gets Nod to Register Liuwei Anshen Capsules"
date: "2025-02-07 15:19:29"
summary: "Chongqing Pharscin Pharmaceutical's received approval from Singapore's Health Sciences Authority to register a Chinese medicine that can be used to treat phlegm and improve sleep, according to a Shenzhen Stock Exchange disclosure on Thursday. The Liuwei Anshen capsules is composed of six herbs, including Rehmannia glutinosa, Ziziphus jujuba seeds and..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Chongqing Pharscin Pharmaceutical's received approval from Singapore's Health Sciences Authority to register a Chinese medicine that can be used to treat phlegm and improve sleep, according to a Shenzhen Stock Exchange disclosure on Thursday.

The Liuwei Anshen capsules is composed of six herbs, including Rehmannia glutinosa, Ziziphus jujuba seeds and lotus seed core. It is among the drugs included in the Chinese drug administration's protected Chinese medicine varieties until September 2031, the pharmaceutical company said.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250207:G2464966:0/)
